Literature DB >> 11698343

Cytostatic effects of 3,3'-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression.

H Leong1, G L Firestone, L F Bjeldanes.   

Abstract

3,3'-Diindolylmethane (DIM), a major in vivo product of indole-3-carbinol (I3C), is a promising anticancer agent derived from vegetables of the Brassica genus including broccoli, Brussels sprouts and cabbage. We report here that DIM has a potent cytostatic effect in cultured human Ishikawa endometrial cancer cells. A combination of northern blot and quantitative PCR analyses revealed that DIM induced the level of TGF-alpha transcripts by approximately 4-fold within 24 h of indole treatment. DIM also induced a 4-fold increase in the activity of the estrogen response marker, alkaline phosphatase (AP). Co-treatment of cells with the estrogen receptor (ER) antagonist ICI, or with the inhibitor of PKA-mediated activation of the ER, H89, ablated the DIM induction of both TGF-alpha expression and AP activity. Furthermore, DIM increased the maximum stimulatory effect of estrogen on TGF-alpha expression. Co-treatment with the protein synthesis inhibitor, cycloheximide, abolished the inductive effects of DIM, indicating differences in the mechanistic requirements of DIM and estrogen. DIM treatment also stimulated levels of secreted TGF-alpha protein by >10-fold. The ectopic addition of TGF-alpha inhibited the growth of Ishikawa cells, whereas incubation with a TGF-alpha antibody partially reversed the growth inhibitory effects of DIM. Taken together, these results extend our previous findings of the ligand independent estrogen receptor agonist activity of DIM, and uncover an essential role for the stimulation in TGF-alpha expression and the TGF-alpha activated signal transduction pathway in the potent cytostatic effects of DIM in endometrial cancer cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698343     DOI: 10.1093/carcin/22.11.1809

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

1.  Indole-3-Carbinol, a Phytochemical Aryl Hydrocarbon Receptor-Ligand, Induces the mRNA Overexpression of UBE2L3 and Cell Proliferation Arrest.

Authors:  Claudia Vanessa Arellano-Gutiérrez; Laura Itzel Quintas-Granados; Hernán Cortés; Manuel González Del Carmen; Gerardo Leyva-Gómez; Lilia Patricia Bustamante-Montes; Miguel Rodríguez-Morales; Israel López-Reyes; Juan Ramón Padilla-Mendoza; Lorena Rodríguez-Páez; Gabriela Figueroa-González; Octavio Daniel Reyes-Hernández
Journal:  Curr Issues Mol Biol       Date:  2022-05-08       Impact factor: 2.976

Review 2.  Minireview: modulation of hormone receptor signaling by dietary anticancer indoles.

Authors:  Gary L Firestone; Shyam N Sundar
Journal:  Mol Endocrinol       Date:  2009-10-16

3.  Artemisinin triggers a G1 cell cycle arrest of human Ishikawa endometrial cancer cells and inhibits cyclin-dependent kinase-4 promoter activity and expression by disrupting nuclear factor-κB transcriptional signaling.

Authors:  Kalvin Q Tran; Antony S Tin; Gary L Firestone
Journal:  Anticancer Drugs       Date:  2014-03       Impact factor: 2.248

Review 4.  Cancer chemotherapy with indole-3-carbinol, bis(3'-indolyl)methane and synthetic analogs.

Authors:  Stephen Safe; Sabitha Papineni; Sudhakar Chintharlapalli
Journal:  Cancer Lett       Date:  2008-05-22       Impact factor: 8.679

Review 5.  Indole-3-carbinol as a chemopreventive and anti-cancer agent.

Authors:  Jing-Ru Weng; Chen-Hsun Tsai; Samuel K Kulp; Ching-Shih Chen
Journal:  Cancer Lett       Date:  2008-03-07       Impact factor: 8.679

Review 6.  A Narrative Review of the Role of Diet and Lifestyle Factors in the Development and Prevention of Endometrial Cancer.

Authors:  Hajar Ku Yasin; Anthony H Taylor; Thangesweran Ayakannu
Journal:  Cancers (Basel)       Date:  2021-04-29       Impact factor: 6.639

7.  Low levels of 3,3'-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol.

Authors:  Maud Marques; Liette Laflamme; Ines Benassou; Coumba Cissokho; Benoit Guillemette; Luc Gaudreau
Journal:  BMC Cancer       Date:  2014-07-21       Impact factor: 4.430

Review 8.  Targeting transforming growth factor-β signalling for cancer prevention and intervention: Recent advances in developing small molecules of natural origin.

Authors:  Devesh Tewari; Anu Priya; Anusha Bishayee; Anupam Bishayee
Journal:  Clin Transl Med       Date:  2022-04

9.  Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3'-diindolylmethane through the mitochondrial pathway.

Authors:  M Nachshon-Kedmi; S Yannai; F A Fares
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.